| Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
|---|---|---|---|---|---|
| PMID:31610510 | IVTH | 0.0000125 M | 0.0000125 M | Decreased pregnenolone levels | Reproductive endocrine-mediated perturbations |
| IVTH | 0.00000625 M | 0.00000625 M | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000625 M | 0.00000625 M | Decrease in corticosterone levels | Neurological endocrine-mediated perturbations | |
| IVTH | 0.00000313 M | 0.00000313 M | Increased testosterone levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000625 M | 0.00000625 M | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.0000125 M | 0.0000125 M | Increased testosterone levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000625 M | 0.00000625 M | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000625 M | 0.00000625 M | Decreased pregnenolone levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000625 M | 0.00000625 M | Increased testosterone levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.0000125 M | 0.0000125 M | Increased estradiol levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.0000125 M | 0.0000125 M | Increased estrone levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000625 M | 0.00000625 M | Increased estrone levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000313 M | 0.00000313 M | Decrease in cortisol levels | Neurological endocrine-mediated perturbations | |
| IVR | 450 mg/kg/day | 450 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
| IVR | 150 mg/kg/day | 150 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
| IVTH | 0.000025 M | 0.000025 M | Affects steroid metabolism | Metabolic endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000078 M | 0.00000078 M | Decrease in cortisol levels | Neurological endocrine-mediated perturbations | |
| IVTH | 0.00000078 M | 0.00000078 M | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
| IVTH | 0.00000078 M | 0.00000078 M | Increased estradiol levels | Reproductive end | |
| IVTH | 0.00000078 M | 0.00000078 M | Decreased pregnenolone levels | ||
| IVTH | 0.00000178 M | 0.00000178 M | Increased estradiol levels | ||
| IVTH | 0.00005 M | 0.00005 M | Decreased testosterone levels | ||
| IVTH | 0.00005 M | 0.00005 M | Decreased estradiol levels | ||
| IVTH | 0.00005 M | 0.00005 M | Decreased pregnenolone levels | ||
| IVTH | 0.00005 M | 0.00005 M | Decreased estrone levels | ||
| IVTH | 0.00005 M | 0.00005 M | Decrease in cortisol levels | ||
| IVTH | 0.00005 M | 0.00005 M | Decrease in corticosterone levels | ||
| IVTH | 0.00000178 M | 0.00000178 M | Decreased progesterone levels | ||
| IVTH | 0.000025 M | 0.000025 M | Decrease in corticosterone levels | ||
| IVTH | 0.000025 M | 0.000025 M | Decreased androstenedione levels | ||
| IVTH | 0.00005 M | 0.00005 M | Decreased androstenedione levels | ||
| IVTH | 0.0000125 M | 0.0000125 M | Affects steroid metabolism | ||
| IVTH | 0.00000178 M | 0.00000178 M | Increased estrone levels | ||
| IVTH | 0.00000178 M | 0.00000178 M | Decrease in cortisol levels | ||
| IVTH | 0.00000178 M | 0.00000178 M | Decreased pregne | ||
| IVTH | 0.00000625 M | 0.00000625 M | |||
| IVTH | 0.0000125 M | 0.0000125 M | |||
| IVTH | 0.000025 M | 0.000025 M | |||
| IVTH | 0.000025 M | 0.000025 M | |||
| IVTH | 0.000025 M | 0.000025 M | |||
| IVTH | 0.00000313 M | 0.00000313 M | |||
| IVTH | 0.0000125 M | 0.0000125 M | |||
| IVTH | 0.00000313 M | 0.00000313 M | |||
| IVTH | 0.00000313 M | 0.00000313 M | |||
| IVTH | 0.00000313 M | 0.00000313 M | |||
| IVTH | 0.000025 M | 0.000025 M | |||
| IVTH | 0.00000313 M | 0.00000313 M | |||
| PMID:33032228 | IVR | 45 mg/kg/day | 45 mg/kg/day | Affects testicular development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
| PMID:35853389 | IVTH | 0.00001 M | 0.00001 M | Reduced sperm quality | Reproductive endocrine-mediated perturbations |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.